Latest Analyst Reports News

Neuren Pharmaceuticals has affirmed the material impact of Acadia’s projection that DAYBUE global net sales could reach approximately US$700 million by 2028, underpinning its royalty revenue outlook.

Boab Metals Limited has responded to ASX concerns over recent unusual trading activity, confirming no undisclosed information exists and attributing the surge to positive research reports and rising silver prices.

DigiCo Infrastructure REIT confirms its FY25 EBITDA slightly exceeded IPO guidance and aligned with analyst forecasts, attributing recent share price declines to the absence of FY26 earnings guidance.

Leeuwin Metals Ltd has addressed a sudden spike in its share price and trading volume, confirming no undisclosed material information exists and attributing the movement to external market factors and a new research report.

Pivotal Metals has clarified the cause behind its recent share price surge, attributing it to a publicly released research note while confirming no undisclosed material information.

Artrya Limited has responded to an ASX price query following a notable surge in its share price, confirming no undisclosed information and adherence to continuous disclosure rules.